Free Delivery Over $100
|
|
|||
|
||||
OverviewAfter the successful introduction of acupuncture to the West, recent advances in analytical methods in chemistry, molecular biology and systems biology – especially the development of the “omic” technologies – have again brought Chinese drugs into the focus of research on Traditional Chinese Medicine (TCM). With more than 1000 publications on the chemistry, molecular biology and pharmacology of TCM drugs in international journals over the last 10 years, Chinese drugs are gaining increasingly reputation and impact. These data offer great opportunities for the development of new pharmaceuticals for various clinical applications. International scientists have compiled relevant and trend setting research results in this book. Topics range from the latest methods of quality and safety assurance by chemical and genetic fingerprints to the development of new pharmaceuticals for a future evidence-based therapy e.g. for cancer, cardiovascular, inflammatory or infectious diseases as well as to recent experimental results on multitarget and synergy research for the preparation of multi-extract-pharmaceuticals from TCM. Full Product DetailsAuthor: Hildebert Wagner , Gudrun Ulrich-MerzenichPublisher: Springer Verlag GmbH Imprint: Springer Verlag GmbH Edition: 2013 ed. Dimensions: Width: 15.50cm , Height: 2.80cm , Length: 23.50cm Weight: 8.073kg ISBN: 9783709117385ISBN 10: 3709117380 Pages: 525 Publication Date: 07 March 2015 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: In Print  This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
